Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michael Olvedy"'
Autor:
Katarina Ochodnicka-Mackovicova, Peter Krenek, Michael Olvedy, Jan Klimas, Frantisek Kristek, Sona Cacanyiova, Peter Ochodnicky, Peter Kruzliak
Publikováno v:
Journal of Cellular and Molecular Medicine
Since the identification of the alternative angiotensin converting enzyme (ACE)2/Ang-(1-7)/Mas receptor axis, renin-angiotensin system (RAS) is a new complex target for a pharmacological intervention. We investigated the expression of RAS components
Autor:
Florian Rambow, Jasmine Barra, Bernard Thienpont, Sara Aibar, Jasper Wouters, Patrice Dubreuil, Enrico Radaelli, Corinna Köhler, Stein Aerts, Julie C. Tisserand, Flavie Luciani, Joost van den Oord, Michael Olvedy, Bram Boeckx, Diether Lambrechts, Sophie Lopez, Paulo De Sepulveda, Jean-Christophe Marine, Sophie Tartare-Deckert
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2017, 127 (6), pp.2310-2325. ⟨10.1172/JCI91291⟩
Journal of Clinical Investigation, 2017, 127 (6), pp.2310-2325. ⟨10.1172/JCI91291⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2017, 127 (6), pp.2310-2325. ⟨10.1172/JCI91291⟩
Journal of Clinical Investigation, 2017, 127 (6), pp.2310-2325. ⟨10.1172/JCI91291⟩
Identification and functional validation of oncogenic drivers are essential steps toward advancing cancer precision medicine. Here, we have presented a comprehensive analysis of the somatic genomic landscape of the widely used BRAFV600E- and NRASQ61K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3925b479efffd3a3b3d3533a365c677
https://hal.archives-ouvertes.fr/hal-01788013/file/91291.2-20170519125209-covered-253bed37ca4c1ab43d105aefdf7b5536.pdf
https://hal.archives-ouvertes.fr/hal-01788013/file/91291.2-20170519125209-covered-253bed37ca4c1ab43d105aefdf7b5536.pdf
Autor:
Elena S. Martens-Uzunova, Guido Jenster, Youri Hoogstrate, Tapio Visakorpi, Mauro Scaravilli, Michael Olvedy
Publikováno v:
Oncotarget, 7(17), 24766-24777. Impact Journals LLC
Oncotarget
Oncotarget
Prostate cancer (PCa) is the most common cancer among men in developed countries. Although its genetic background is thoroughly investigated, rather little is known about the role of small non-coding RNAs (sncRNA) in this disease. tRNA-derived fragme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ad25a45d04e2256f0dac8e931dc07f9
https://pure.eur.nl/en/publications/b148e7df-a7d4-4c31-81ae-f64ebaf22b15
https://pure.eur.nl/en/publications/b148e7df-a7d4-4c31-81ae-f64ebaf22b15
Publikováno v:
Cancer Letters, 340(2), 201-211. Elsevier Ireland Ltd
Cancer Letters; Vol 340
Cancer Letters; Vol 340
Over the recent years, Next Generation Sequencing (NGS) technologies targeting the microRNA transcriptome revealed the existence of many different RNA fragments derived from small RNA species other than microRNA. Although initially discarded as RNA t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e268c0baa0e1a977fc6fcec592c82c40
https://pure.eur.nl/en/publications/37d31d2d-36b2-47c8-8e03-1fcf9cb199de
https://pure.eur.nl/en/publications/37d31d2d-36b2-47c8-8e03-1fcf9cb199de